Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merrion Pharmaceuticals Ltd.

www.merrionpharma.com

Latest From Merrion Pharmaceuticals Ltd.

Looking For The New Lantus: Next-Gen Diabetes Hopefuls Defy Risks

The diabetes market presents competitive, commercial, and regulatory challenges, but its size and breadth spur emerging biotechs to develop an ever-wider range of treatments and technologies.

BioPharmaceutical Clinical Trials

Deals Of The Week Keeps Tabs As Tax Trimming Fuels Deal-Making

As more biopharmaceutical companies become profitable and global, tax strategy becomes an increasingly important aspect of deal-making and intellectual property management. Deals of the Week looks at recent tax winners, new tax tactics and potential deal targets that are attractive in part because of their high – or low – tax rates.

BioPharmaceutical Deals

Novo Nordisk Looks Ahead After Tresiba Setback, Bets Against Biosimilars

The Danish pharma is focused on the latest formulation technology for insulin and GLP-1 and combinations thereof to sustain its diabetes market leader position. It’s not particularly worried about biosimilars, despite two of its top sellers coming off-patent in the next few years.

BioPharmaceutical Asia Pacific

Drug delivery deals reflect biologics progress

While most drug delivery deal-making traditionally revolves around products that have been launched or specialty products to extend and protect a product's market position, a new study from the Indian consulting and investment advisory firm, MP Advisors, suggests a growing trend for early stage agreements.

Metabolic Disorders
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
    • Vaccines
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Adaptiv Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Ireland
  • Parent & Subsidiaries
  • Merrion Pharmaceuticals Ltd.
  • Senior Management
  • John Lynch, CEO
    Jonathan O’Connell, CFO
    Thomas W Leonard, PhD, VP & CSO
    Hing Kin Chan, PhD, CBO
  • Contact Info
  • Merrion Pharmaceuticals Ltd.
    Phone: (353) 1.672.9272
    Biotechnology Bdg.
    Trinity College
    Dublin,
    Ireland
Advertisement
Advertisement
UsernamePublicRestriction

Register